Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.738.635.795.754.70

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.73
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.73
1.16
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,250.9 Cr -0.7% 6.1% 9.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,048.0 Cr 0.5% 4.6% 11.7% Stock Analytics
DIVIS LABORATORIES ₹177,179.0 Cr -0.6% 2.2% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,804.0 Cr 3.2% 8.1% 43.9% Stock Analytics
CIPLA ₹117,642.0 Cr 1.1% 5.6% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹112,368.0 Cr -0.3% 5.6% -0.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-0.7%

6.1%

9.2%

SENSEX

0.7%

4.4%

-5.6%


You may also like the below Video Courses